Search
Oragenics Inc
OGENAdd to Watchlist
0.520USD
0.0000.00%
Market hours 08/25, 10:16（ET）
2.35MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-24No earnings forecast score is currently available for Oragenics Inc. The Biotechnology & Medical Research industry's average is 8.09. The average price target is 2.00, with a high of 2.00 and a low of 2.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
2.000
Target Price
+308.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Oragenics Inc
OGEN
0
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
26
Kymera Therapeutics Inc
KYMR
24
IQVIA Holdings Inc
IQV
24
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Oragenics Inc's price target?
Analysts forecast that Oragenics Inc's price target is USD 2.00, with the highest forecast at USD 2.00 and the lowest forecast at USD 2.00.